Loading...
Diversely Functionalised Cytochalasins through Mutasynthesis and Semi-Synthesis.
Wang, Chongqing ; Lambert, Christopher ; Hauser, Maurice ; Deuschmann, Adrian ; Zeilinger, Carsten ; Rottner, Klemens ; ; Stadler, Marc ; Skellam, Elizabeth J ; Cox, Russell J
Wang, Chongqing
Lambert, Christopher
Hauser, Maurice
Deuschmann, Adrian
Zeilinger, Carsten
Rottner, Klemens
Stadler, Marc
Skellam, Elizabeth J
Cox, Russell J
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2020-06-02
Submitted date
Files
Loading...
Open Access publication
Adobe PDF, 3.41 MB
Other Titles
Abstract
Mutasynthesis of pyrichalasin H from Magnaporthe grisea NI980 yielded a series of unprecedented 4'-substituted cytochalasin analogues in titres as high as the wild-type system (≈60 mg L-1 ). Halogenated, O-alkyl, O-allyl and O-propargyl examples were formed, as well as a 4'-azido analogue. 4'-O-Propargyl and 4'-azido analogues reacted smoothly in Huisgen cycloaddition reactions, whereas p-Br and p-I compounds reacted in Pd-catalysed cross-coupling reactions. A series of examples of biotin-linked, dye-linked and dimeric cytochalasins was rapidly created. In vitro and in vivo bioassays of these compounds showed that the 4'-halogenated and azido derivatives retained their cytotoxicity and antifungal activities; but a unique 4'-amino analogue was inactive. Attachment of larger substituents attenuated the bioactivities. In vivo actin-binding studies with adherent mammalian cells showed that actin remains the likely intracellular target. Dye-linked compounds revealed visualisation of intracellular actin structures even in the absence of phalloidin, thus constituting a potential new class of actin-visualisation tools with filament-barbed end-binding specificity.
Citation
Chemistry. 2020 Jun 2. doi: 10.1002/chem.202002241.
Publisher
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
EISSN
1521-3765
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution-NonCommercial-ShareAlike 4.0 International
